An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders
1 other identifier
observational
200
1 country
2
Brief Summary
The diagnostic cohort study could will be use to verify the clinical performance of the AQP4 -immunoglobulin G detection kit and whether it has a good correlation with the clinical diagnosis results. The applicability and accuracy of the kit in clinical diagnosis will be verified according to the measured data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2020
CompletedFirst Posted
Study publicly available on registry
May 14, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2021
CompletedFebruary 3, 2022
January 1, 2022
7 months
May 10, 2020
January 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
results of AQP4 -immunoglobulin G detection kit
The Serum test results of participants using AQP4 -immunoglobulin G detection kit
through study completion, an average of 6 months
Eligibility Criteria
Patients with NMOSD who are diagnosied in the First Affiliated Hospital of Fujian Medical Universtiy by two neurolgists
You may qualify if:
- The patients who were diagnosed with NMOSD , and the cell-based assay was used to determine the AQP4-IgG-seropositive patients;
- AQP4-IgG is negative in health people with age and sex matching and determined by cell-based assay;
- Female or male, age 14-80;
- Patients or authorized family members volunteered to participate in this study and signed informed consent.
You may not qualify if:
- Patients with coagulation disorders;
- Infection-related encephalitis;
- Immune-related encephalitis;
- A patient with severe mental illness who cannot cooperate clinically;
- A patient with severe jaundice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Neurology,First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350005, China
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
May 10, 2020
First Posted
May 14, 2020
Study Start
May 15, 2020
Primary Completion
December 1, 2020
Study Completion
February 20, 2021
Last Updated
February 3, 2022
Record last verified: 2022-01